This site is intended for healthcare professionals only
LoginRegister
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorderUCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
Full Inspection of Packaged Water Units in Maharashtra Mandatory, Says FSSAIFull Inspection of Packaged Water Units in Maharashtra Mandatory, Says FSSAI
Pharma Firms To Face Periodic Inspection As HC Flags Effluent RisksPharma Firms To Face Periodic Inspection As HC Flags Effluent Risks
AstraZeneca expands Global Hub in Bangalore with Rs 166 crore investmentAstraZeneca expands Global Hub in Bangalore with Rs 166 crore investment
Merck to begin Phase 3 trials for investigational once monthly HIV prevention pillMerck Enflonsia wins ACIP backing for RSV protection in infants under 8 months
CDSCO Panel Accepts Phase I Trial Data for Intas Denosumab BiosimilarIntas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated
label updates for Bristol Myers Squibb 2 CAR T cell therapiesUSFDA approves label updates for Bristol Myers Squibb 2 CAR T cell therapies
Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopauseBayer Eylea 8 mg with extended 6-month treatment interval approved in EU for retinal diseases
Abbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol WithdrawalAbbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine
Aurobindo Pharma recallSafety first: Aurobindo recalls discolored pain relieving drug in US
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapies
X